Platelets >= 75 x 10^9/L within 30 days of day 1 of study Platelets >= 100,000/ul Platelets >= 100 x 10^3/uL Platelets >= 100,000/ul Platelets >= 100 x 10^9/L within 14 days prior to registration. Platelets >= 100,000 Platelets >= 100,000/ul Platelets >= 75,000 g/uL Platelets >= 100,000 cells/uL (75 x 10^9 L); and, Platelets >= 100,000/uL Platelets >= 100 X 10^9/L Platelets >= 100 x 10^9/L. Platelets >= 100,000/ul (within 14 days of treatment initiation) Platelets >/= 100 × 109/L Platelets >= 100,000/ul Platelets >= 100 x 10^9/L Platelets ? 100 × 109/L Platelets ? 100,000/uL Platelets ? 100,000/mL Platelets >= 100 x 10^9/L Platelets ?100 x 109/L Platelets ?75,000 µL Platelets >= 100,000/uL Platelets >= 75 x 10^9/L Platelets >= 100 × 10^9/L Platelets (Plt) >= 30,000 x 10^9/L Platelets >= 100,000/uL Platelets >= 100 x 10^9/L Platelets >= 100 x 10^9/L Platelets >= 100 x 10^9/L Platelets >= 100,000/uL Platelets >= 75,000/ul Platelets >= 100 K/uL Platelets ? 75,000/ul Platelets ?100,000 ?L. Platelets >= institutional lower limit Obtained within 14 days prior to C1D1: Platelets >= 100,000 4/uL Platelets ?100 × 10?9/L; Platelets 100,000/ul or more Obtained =< 21 days prior to registration: platelets (PLT) >= 50,000/uL Platelets >= 75,000/uL Platelets >= 100,000/uL platelets: ? 100 x 109/L Platelets >= 100 x 10^9/L Platelets >= 100 K/uL Platelets >= 75,000/uL Platelets < 100,000/µL Platelets >= 100 K/uL Platelets >= 100 x 10^9/L Platelets >= 100,000/uL Documented within 14 days of registration: Platelets >= 75,000/ul (unsupported) Platelets >= 100 x 10^9/L, determined within 14 days of registration Within 28 days of study registration: Platelets >= 100 x 10^9/L Platelets >= 100 K/uL Platelets >= 100,000/microliter Platelets ? 75 x 10^9/L Chemistry: Platelets ? 100,000/uL within 28 days prior to registration Platelets ? 60 K/uL Platelets >= 100,000/L Platelets >= 75 x 10^9/L, at the screening visit Platelets >= 100 x 10^9 (without platelet transfusion) Platelets ? 75,000/?L Platelets >= 100,000/mL Platelets ?100×109/L (w/o transfusions w/in 21 days) Within 14 days prior to registration: Platelets >= 100,000/uL Platelets <100 x 109/L Platelets >= 50,000/uL; a subject will not be excluded because of pancytopenia related to disease Platelets >= 75 x 10^3/uL Platelets (PLT) >= 100,000/uL Platelets >= 100 x 10^9/L Platelets >= 100,000 cells/ul Platelets ?75 x 109/L INCLUSION - TREATMENT: Platelets > 50,000/ul Platelets >= 75,000 total Platelets >= 100 X 10^9/L Platelets >= 100,000 cells/ul Platelets >= 100,000/uL Platelets >= 100,000/uL Platelets >= 100,000/uL Platelets >= 100 x 10^9/L Platelets >= 75 K/uL Platelets >= 100,000/uL Platelets >= 75,000 Thrombocytopenia (platelets [Plt] < 100,000/ul) Platelets >= 100 x 10^9/L Platelets >= 100,000/uL within 14 days prior to first dose of protocol-indicated treatment. Platelets >= 100 × 10^9/L. Within 14 days of the first dose of study drug: Platelets >= 100 x 10^3/uL Platelets >= 100 x 10^9/L Platelets > 70,000/uL Platelets >= 100 x 10^9/L Within 10 days prior to the start of study treatment: Platelets >= 100 000/uL Platelets ? 75,000/microliter Platelets >= 100 x 10^3/uL. Within 28 days prior to registration: Platelets >= 100 x 10^9/L Platelets >= 100,000/uL Platelets > 50,000/uL. Platelets ? 20,000/uL Platelets >= 100 x 10^3/uL Platelets >= 75,000/microliter Platelets ? 100 x 109/L Platelets >= 100 k/uL Obtained within 14 days prior to randomization/registration: platelets >= 100 x 10^3/uL Platelets >= 100,000/dl Platelets ? 100,000/uL Platelets >= 75,000/ uL, within 2 weeks of registration Platelets >= 50,000/uL Platelets >= 75,000 cells/uL Platelets >= 100,000/ul Platelets (PLT) ? 100 Platelets >= 100,000/uL Platelets > 100,000/uL Platelets 100,000/ul or more Platelets > 100,000/ul Platelets >= 100,000/ul Platelets 100,000/ul or more Platelets >= 100,000/ul. Platelets >= 60,000/Ul. Platelets >= 100 K/UL Platelets (plt) >= 100 x 10^9/L Platelets ? 100 x 10^9/L Platelets >= 100,000 x 10^9 /L Platelets >= 100,000/uL Platelets >= 100,000/ul (unsupported) Platelets >= 125,000 cells/ul (prior to biopsy) Within 14 days of the first dose of the study drugs: Platelets >= 75,000/L. Platelets >= 100,000/uL. + 0 for (platelets <50), +1 for (platelets >50). Platelets >= 100,000/uL Within 28 days prior to enrollment: Platelets >= 100,000/uL Obtained within 21 days prior to randomization/registration: Platelets >= 100 x 10^3/uL. Platelets >= 100 x 10^9/L Platelets >= 100 x 10^9/L (For patients with hepatocellular carcinoma, platelets >= 70 x 10^9/L). Platelets < 100 x 10^9/L No more than 14 days prior to registration: Platelets >= 100,000/uL Platelets >= 50,000/uL Performed within 14 days of treatment initiation: Platelets >= 100,000/uL Platelets >= 100 x 10^9/L Platelets > 10 x 10^9/L Platelets >= 100,000/ul Platelets >= 100 x 10^9/L Platelets >= 150,000/ul Platelets >= 100,000/uL Platelets >= 75,000/ L Platelets (plts) > 100 x 10^9/L Platelets > 100 x 10^9/L Platelets >= 100,000/uL Platelets >= 100 x 10^9/L Platelets > 100 x 10^9/L without transfusion Platelets >= 100,000/uL Platelets >= 100 x 10^3/uL Platelets >= 100,000/ uL, within 2 weeks of registration (except where specified otherwise) Platelets (PLT) >= 100 x 10^3/uL, within 30 days before study registration Platelets >= 75,000/uL (For both cohorts A and B): Platelets >= 100 x 10^9/L Platelets >= 100,000 /uL Platelets ? 75,000/µl Platelets >= 100,000/uL Platelets =< 100,000/uL Platelets >= 100x10^3/uL Platelets >= 75,000/uL Platelets >= 100,000/uL obtained < 4 weeks prior to starting treatment Platelets >= 75 x 10^9/L Platelets >= 100 x 10^9/L Platelets ? 75 x 109/L Platelets >= 75,000 Obtained within 14 days of randomization: Platelets >= 100 x 10^3/uL Platelets >= 100,000/mL. Platelets >= 100,000/ul Platelets >= 100 x 10^9/L Platelets >= 100,000 cells/ml Platelets >= 100 x 10^9/L Platelets >= 75 X 10^9/L Platelets >= 100 X 10^3/uL Platelets < 100,000 cells/uL Platelets >= 100 x 10^9/L Platelets >= 75,000 per microliter Platelets >= 100,000/uL Platelets >= 100 x 10^9/L Platelets >= 100,000/uL within 14 days prior to study entry Platelets >= 100 x 10^9/L Platelets >= 100 x 10^9/L Platelets >= 100 x 10^3/uL Platelets >= 100,000/uL (performed within 28 days of registration) Platelets >= 100 X 10^9/L Platelets >= 75 x 10^3/uL should be obtained within 21 days prior to enrollment Platelets >= 80 x 10^9/L Platelets >= 75,000/uL at screening visit Platelets >= 100 x 10^9/L Platelets >= 75,000/uL at screening visit Platelets >= 100 x 10^9/L Platelets =< 50,000 Platelets ? 100 × 10^9/L Platelets >= 60,000/uL performed within 7 days of treatment initiation Platelets > 75,000/uL Platelets < 100 x 10^9 /L Platelets >= 75,000 cells/uL Platelets >= 100,000/uL Platelets >= 100 x 10^3 /uL Platelets < 100,000/mL Platelets >= 100,000/mL Platelets >= 100,000 x 10^9/L Platelets >= 100 x 10^9/L:\r\n* Unless due to bone marrow infiltration then eligible if platelets > 50 x 10^9/L) Platelets > 70,000/uL Platelets >= 75,000 Platelets >= 100 x 10^9/L Platelets >= 50,000/uL Platelets >= 75,000/dL Platelets >= 100 x 10^9/L Platelets ? 100,000/?L Platelets >= 100,00/uL Platelets >= 100,000 per uL Platelets >= 100 x 10^3/uL Platelets > 100,000/uL Platelets >= 100,000/uL Platelets >= 100 x 10^9/L Platelets < 20,000/ul prior to treatment Platelets > 75,000/L Platelets >= 100 x 10^9/L Platelets >= 50 x 10^9/L (without transfusion support) Platelets >= 100,000 Platelets >= to 100,000 /uL Platelets >= 100,000/mL Platelets ? 100 x 109 cells/L Platelets ? 100000/L Platelets >= 50,000/uL Platelets >= 100,000/uL platelets ? 100x10^9/L Platelets (PLT) >= 75 x 10^9/L without transfusions Platelets >= 100,000/ul, (75,000/ul if due to bone marrow [BM] involvement) Platelets >= 100,000/uL obtained within 14 days of first treatment Platelets ? 100 x 109/L. Platelets >= 100 x10^3/uL obtained within 14 days prior to randomization/registration Platelets >= 100,000 x 10^9/L Platelets >= 100,000/µL Within 14 days prior to registration: Platelets >= 100,000 x 10^9/L Platelets ? 100,000/?l Platelets >= 100,000 cells/ul Platelets >= 100 x 10^9/L Platelets >= 100 x 10^3/uL Platelets >= 100,000/uL Platelets >= 75 x 10^9/L Platelets >= 100,000/uL Platelets >= 100,000/mL Platelets ? 75,000/?L Platelets >= 75 x 10^9/L Platelets >= 100 x 10^9/L Platelets > 100000 within 30 days of consent Platelets > 100000 within 45 days of consent Platelets > 100 x 10^9/L within 14 days of study entry Platelets >= 100 x 10^9/L Platelets ? 150,000 x 10^6 cells/L Documented platelets >= 80,000 Platelets >= 100 x 10^3/uL Platelets >= 100,000/ul Platelets >= 100,000/uL Platelets >= 80 x 10^9/L Platelets < 100 x 10^9/L Platelets > 100,000/ul (transfusion independent) Platelets >= 100,000/uL Platelets <100 x 109/L Platelets >= 100,000/microliter Platelets >= 100k Platelets >= 75 x 10^9/L Platelets (Plts) >= 100,000 /uL Platelets > 100,000/ul Platelets >= 100 x 10^9/L, obtained within 30 days of study registration Platelets >= 75 K Platelets >= 100 x 10^9/L Platelets >= 100,000/uL within 14 days of the first dose of study drug Platelets >= 100,000/dl Platelets >= 100 x 10^9/L Platelets > 100,000 cells/ul platelets ? 100 x 10^9/L Platelets >= 75 k/uL Platelets >= 100 x 10^9/L Platelets >= 50 x 10^9/L Platelets >= 50,000 x 10^9/L Platelets >= 100 x 10^9/L Platelets > 100 x 10^9/L Platelets >= 100,000/uL Platelets >= 100 x 10^9/L Platelets >= 50 x K/uL Platelets >= 100,000/ul Platelets >= 100 x 10^9/L Platelets >= 100,000 cells/ul Platelets >= 75 x 10^3/uL Within 14 days prior to registration: Platelets >= 100 x 10^9/L Platelets > 75 x 10^9/L Platelets >= 100,000/µL Platelets >= 100 x 10^9/L Platelets >= 100,000/ul Platelets > 50 k/ul Platelets > 100,000/ul (transfusion independent) Platelets >= 50 x 10^9/L Platelets >= 75,000/uL (within 2 weeks prior to radiotherapy) ANC >/=1 x10(9)/L and platelets >/=100 x10(9)/L. Platelets >= 120,000/uL Platelets (PLT) >= 100,000 uL Platelets > 50,000/uL Platelets >= 100 x 10^9/L Platelets >= 100,000 /uL Platelets (Plt) >= 75,000 Platelets >= 100,000 per uL Platelets >= 100 x 10^3/uL Platelets >= 100,000/uL Platelets >= 50,000/mL Platelets >= 100 x 10^9/L Platelets >= 75,000/mL Platelets >= 75,000/mL Platelets > 75,000/uL Platelets >= 100 x 10^9/L Platelets >= 100 x 10^9/L (transfusion dependent) Platelets >= 100,000/mL Platelets >= 100,000/uL (non-transfused) Platelets =< 75,000/ul Platelets >= 100 x 10^9/L Platelets >= 100K Platelets > 100,000/ul (transfusion independent) Platelets >= 100,000/ul Platelets > 100,000 Platelets > 100,000/ul Platelets > 50 x 10^9/L without transfusion in the prior 7 days Platelets ? 100 x 109/L Platelets ? 100,000/µL platelets ? 100,000/?L, Platelets >= 70,000 /uL Platelets ? 100,000/µL (?100 x 10^9/L) Platelets > 50 x 10^9/L Platelets <100 X 109/L Platelets ? 100,000/?L Platelets (PLT) >= 100,000 Platelets >= 100 x 10^3/ul Platelets >= 100 x 100/L Platelets ? 100 x 109/L Platelets >= 100,000/uL Platelets >= 100,000. Platelets >= 100,000/uL Platelets ? 75 x 109 cells/L Platelets >= 100,000/microliter Platelets (PLT) >= 100 x 10^9/L without transfusions Platelets >= 100,000/mL Platelets >= 100,000/mL Platelets >= 100 x 10^9/L Platelets >= 100 × 10^9/L =< 14 days prior to registration Platelets (PLT) >= 100,000/uL Platelets >= 100,000 Platelets >= 100 x 10^9/L Platelets >= 100 x 10^9/L Platelets > 100 x 10^9/L Platelets >= 100 x 10^9 / L Platelets >= 100 x 10^9/L Platelets >= 100,000/ul Platelets >= 75 x 10^9/L Platelets >= 100 x 10^9/L Platelets >= 100 x 10^9/L Platelets >= 100,000/uL Platelets >= 100,000/uL TUMOR BIOPSY SEQUENCING: Platelets >= 100,000/uL (mcL) Platelets >= 100 x10^3/uL Platelets 100,000/ul or more Platelets >= 100 x 10^9/L Platelets >= 100 x 10^9/L Platelets > 100,000/uL Platelets >= 75,000/uL Platelets >= 10 x 10^9/L Secondary Registration: platelets >= 100,000/uL Platelets >= 100 x 10^9/L Platelets >= 100,000/uL Platelets (PLT) >= 100,000/uL Platelets > 100,000/uL Platelets > 50,000/ul Platelets > 50,000/uL Platelets >= 100,000/uL (untransfused) Platelets (PLT) >= 100,000/uL Platelets >= 100 x 10^3/uL Platelets >= 100,000/uL Platelets >= 100,000/uL Platelets >= 90 x 10^3/uL Platelets >= 100 × 10^9/L Platelets >= 100,000/ul Platelets >= 100 × 10^9/L Platelets >= 100 x 10^9/L Within 14 days of subject registration: Platelets 100,000/uL (no transfusion allowed within 2 weeks) Platelets > 150,000 Platelets >= 100,000/uL Platelets >= 100,000/ul Platelets >= 100,000/uL Platelets >= 100,000/uL Platelets >= 100,000/uL Platelets >= 100,000/uL Platelets > 50,000 per microliter Platelets >= 100 x10^9/L Platelets >= 50 x 10^9/L Platelets >= 100 x 10^9/L, within 2 weeks of the first dose of study treatment Platelets >= 100 x 10^9/L Platelets >= 50,000 Hematologic criteria: ANC < 500/uL, Platelets < 25,000 uL. Platelets >= 100 x 10^9/L Platelets (PLT) >= 100,000/ul Platelets >= 100 x 10^3/uL Platelets >= 100,000/uL Platelets >= 100 x 10^9/L Platelets >= 100,000/uL Platelets > 50k/ul Platelets >= 100 x 10^3/uL Platelets >= 100 x 10^3/uL Platelets >= 100,000/mL Platelets >= 100,000/ml Platelets >= 50,000/uL Platelets > 100,000/ul Platelets > 100 x 10^9/L without transfusion Thrombocytopenia (platelets [Plt] < 100,000/ul) Platelets >= 100 x 10^9/L Platelets >= 100,000/uL Platelets (plt) ? 100 x 109/L, Performed within 14 days of patient registration: Platelets >= 100,000/uL (no transfusion allowed within 2 weeks) Platelets >= 100,000/ul Platelets > 75,000/uL Platelets >= 100 x 10^9/L. Platelets >= 75 x 10^3/uL Platelets (PLT) >= 100,000 Platelets > 100,000/uL Platelets < 75,000 Platelets >= 160,000/ul Platelets ? 75 x10?/L Platelets ?100,000/uL (microliter) Platelets ? 100,000 cells/ml, Platelets >100,000/mL (without platelet transfusion within the last 2 weeks) Platelets ? 100 x 10^9/L Platelets ? 30 x 10^3/uL Platelets > 90 x 10^9/L Platelets ? 60 x 109/L. Platelets (plt) ? 100 x 109/L. Platelets (Plt) ?100 x 109/L. Platelets >= 100,000/ul Platelets >= 100 x 10^3/uL Platelets >= 100 x 10^3/uL Platelets >= 75 x 10^3/uL Platelets >= 100 x 10^9/l Platelets >= 100,000/ul Platelets ?100,000/?L Platelets < 100x109/L Platelets ?100,000 / mL Platelets (PLT) <75 x 109/L (75x103/µL) Platelets > 100,000/ul Platelets >= 100 x 10^9/L Platelets >= 100,000/uL Platelets ? 75 x 103/?L Platelets >= 100,000/uL Platelets < 100000/ml Platelets >=100,000/uL. Platelets >= 100 x 10^9/L Platelets >= 75,000/ul Platelets: >= 100,000/uL Platelets >= 100 x 10^9/L Platelets >= 100 x 10^9/L Platelets >= 100 x 10^3/uL Platelets >= 100,000/uL Platelets > 100,000/uL Platelets >= 75,000/uL Platelets >= 100,000/L Platelets > 100,000/?L Platelets >= 75,000/microliter Platelets >= 100 x 10^9/L Platelets (PLT) >= 100,000/uL Platelets >= 100,000/uL Platelets >= 50000/uL Platelets >= 100,000 /uL Platelets > 75,000/µl Platelets >= 100 x 10^9/L Platelets (PLT) > 75,000/ul Platelets of > 100 x 10^9/L Platelets >= 100,000/ul (untransfused) Platelets >= 100 x 10^9/L. Platelets >= 100,000 Platelets >= 100,000/uL obtained =< 7 days prior to randomization Platelets >= 75 x 10^9/L Platelets > 100 x10^3/uL Platelets < 100000/ml Platelets >= 50,000/uL Platelets >= 100,000/uL Platelets >= 200 x 10^9/L Platelets >= 50,000/uL Platelets (Plt) > 100 Platelets >= 100,000/uL Platelets >= 75 x 10^3/uL Platelets ? 100 x 10^9 cells/L Platelets >= 100 X 10^9/L Platelets > 100,000/uL Within 4 weeks of administration of study therapy: Platelets >= 100,000/uL Platelets >= 20,000 without platelet transfusion Platelets < 50,000 x 10^9/L. Platelets >= 75 x 10^9/L, performed within 28 days of treatment initiation Platelets >= 100 x 10^3/uL Platelets < 50,000/ul Platelets >= 100,000/ul Platelets >= 100x10^9/L Platelets >= 125,000 cells/ul Platelets (plt) >= 100 x 10^9/L Platelets ? 100 x 10?/L Platelets (PLT) >= 50,000 mL Platelets >= 160 x 10^9/L Platelets >= 100,000/mL Platelets >= 100 x 10^9/L Obtained =< 21 days prior to registration: Platelets (PLT) >= 50,000/uL Platelets >= 100,000/?L Platelets >= 100 x 10^9/L Platelets >= 100,000/uL Platelets >= 100,000/ul Platelets >= 100 × 10^3/uL Platelets >= 100 x 10^9/L Platelets>=100 x 10^9/L Platelets >= 50,000/uL Platelets ? 75,000/?L Platelets >= 50,000 cells/uL within 14 days before enrollment Platelets >= 100 x 10^9/L Platelets ?100,000/?L Platelets >= 75 x 10^3/uL Platelets >= 75 x 10^3/uL Platelets >= 100,000/mL Platelets ?75000/µL Platelets >= 100,000/ul Platelets ? 75 × 109/L. AT THE TIME OF INFUSION: Platelets > 50,000/ul Platelets >= 100,000/uL Platelets >= 100,000/uL Platelets >= 100,000/mL Platelets >= 100,000/uL Platelets =< 50,000 Platelets ?100 x 10^9/L. COHORT A: Platelets >= 75 x 10^3/uL COHORT B: Platelets >= 75 x 10^3/uL Platelets >= 100 X 10^9 cells/L Platelets ? 100,000/µL Platelets >= 100,000 ml Platelets >= 100,000/ul (unsupported) Platelets (PLT) >= 100,000 / uL Platelets >= 90 x 10^3/uL Platelets > 100,000 Platelets > 75,000/uL Platelets >= 50,000/ul Platelets >= 100 x 10^9/L Platelets >= 75,000/uL Platelets (PLT) >= 100,000/uL Platelets >= 100 x 10^9/L Platelets >= 100 x 10^9/L Platelets >= 100,000/ul Platelets >= 50,000 cells/uL (50 x 10^9/L) Platelets >= 100,000/ul (no transfusion allowed within 2 weeks) Platelets >= 100,000/uL Platelets (plt) >= 100 x 10^9/L Platelets >= 75,000/uL Platelets >= 100 x 10^9/L Platelets >= 100 K/UL Platelets >= 100 X 10^9/L Platelets > 100,000/µL Platelets >= 100,000 per uL Platelets >= 100 x 10^9/L Platelets >= 100 x 10^9/L Platelets (plt) >= 100 x 10^9/L Platelets ? 100 x 10^9/L Platelets ? 100 x 10^9/L. Platelets >= 50,000/mL Platelets >= 100,000/uL Platelets >= 50,000/uL Platelets >= 100 x 10^9/L Platelets >= 100,000/uL Platelets >= 50,000/uL Platelets >= 75 x 10^9/L Platelets >= 100,000/uL Platelets (PLT) =< 100K Platelets ? 100 x 109/L Platelets >= 75 x 10^9/L Platelets < 75 x 10^9/L Platelets >= 100,000/uL Platelets >= 100 x 10^9/L Platelets < 50 x 10^9/L Platelets >= 50,000 (50 x 10^9/L) Platelets >= 100,000/uL Platelets >= 75,000 per uL Platelets >= 100,000/ul Platelets < 100,000 /uL Platelets > 80,000 Low platelets (< 75 k/ul) Platelets >= 100 x 10^3/uL Platelets >= 100,000 Platelets >= 50,000/mL Platelets >= 100 X 10^9/L Platelets >= 100,000/uL Platelets >= 100,000/Ul Platelets > 100,000/uL prior to day 0 Platelets >= 100 x 10^9/L Platelets > 75,000/uL Platelets >= 100,000/uL Platelets >= 100 X 10^9/L Platelets > 50,000 (platelet transfusion allowed) The patient has an absolute neutrophil count (ANC) ?1000/µL, platelets ?100,000/µL and is not transfusion dependent for platelets and/or red cells Platelets > 100,000/mL Within 14 days after subjects signed the treatment consent: Platelets >= 100,000/ul Platelets >= 50 x 10^3/uL Platelets >= 100,000/uL Platelets >= 100 x 10^9/L (without transfusion < 14 days before enrollment) Platelets >= 100 x 10^3/uL Platelets (PLT) >= 75,000/ul Platelets >= 100 X 10^9/L Platelets: >= 75 x 10^3/uL (~ 75 x 10^9/L) Platelets >= 100,000/uL Platelets >= 100 x 10^9/L Platelets >= 100 X 10^9/L Platelets >= 100,000/uL Platelets > 100 x 10^9/L Platelets >= 100 x 10^9/L Platelets >= 100,000/uL Platelets > 100 K Platelets >= 100,000/uL, within 14 days of registration Platelets >= 100 x 10^9/L Platelets > 100,000/ul Platelets >= 100 x 10^9 cells/L Platelets >= 100,000/?L Platelets >= 100,000/uL Platelets >= 100 x 10^9/L Platelets >= 50,000/mL Platelets >= 100,000 Platelets >= 100,000/ul Platelets >= 100 x 10^9/L (must be independent of platelet transfusion) Platelets >= 30,000/uL Platelets >= 75,000/ul Platelets >= 50,000/mL SORAFENIB ARM: platelets >= 75,000/mL Platelets > 50,000 Platelets >= 75 x 10^9/L Platelets >= 100 x 10^3/uL Platelets >= 100,000/uL Within 14 days prior to enrollment/randomization: Platelets >= 100,000/uL Platelets ? 75,000/?L (without intervention, e.g., transfusion) Platelets >= 50,000/uL Platelets >= 50,000/mL Platelets >= 100,000 cells/ul Platelets > 50,000/uL Platelets > 50,000/uL Platelets >= 50,000 uL PRIOR TO POST-TRANSPLANT IMMUNOTHERAPY: Platelets > 50,000/uL Platelets > 100,000/ul Platelets >= 100,000/ul (unless low platelets are due to multiple myeloma) Platelets > 100,000/ul Platelets (PLT) >= 50,000/uL Platelets > 75,000 cells/ul Platelets of at least 75,000 x 106/L Platelets of 75K Platelets >= 100 x 10^9/L Platelets > 100 x 10^9/uL Platelets (PLT) > 100,000/ml Platelets (PLT) >= 100 x 10^9/L without transfusions Platelets >= 100,000/uL Platelets < 100,000/ml Platelets >= 80 x10^9/L Platelets >= 100,000//uL Platelets >= 100,000/uL Platelets >= 75,000 Platelets: >= 75 x 10^3/uL (~75 x 10^9/L) Platelets < 100 x 109/L Platelets >= 100,000/uL Platelets >= 50,000 cells/uL, or >= 30,000/uL if bone marrow is involved by malignancy Platelets ?100,000/?L Platelets ? 100 Platelets >= 50 X 10^9/L Platelets (PLT) >= 100,000 Platelets ? 50 X 10³/µL Platelets >= 50.0 x 10^9/L Platelets > 100,000/uL Platelets ? 100,000//microL Platelets >= 100,000/uL Platelets >= 100,000/ul Platelets ? 100,000/µL (? 100 x 103/µL) Platelets >= 100,000/ul Platelets >= 100 x 10^9/L Platelets ?100,000/?L; Platelets >= 80,000 x 10^9/L Platelets <75,000/?L Platelets > 50,000/uL Platelets >= 100 x 10^9/L Platelets >= 75 K/uL (transfusions are permissible) Platelets >= 100 x 10^9/L Platelets: >= 75,000/ul Platelets >= 100 x 10^3/uL Platelets >= 100,000 /uL without transfusion within 10 days prior to dose Platelets >= 100,000/uL Platelets ?75,000 /mL Platelets >= 75,000/uL Platelets ? 100 × 10³/µL Platelets >= 75,000/uL Platelets >= 100,000 Platelets (plt) >= 100 x 10^9/L Platelets ? 75,000 /mL; Platelets >= 50,000 Platelets >= 50,000 Platelets >= 100 x 10^9/L Platelets ? 100 × 109/L; Platelets >= 75,000 Platelets >= 50000/uL Platelets ? 100 x 10^9, Hb ? 90 g/L, ANC ? 1.5 x 10^9/L. Platelets >= 100,000/ul Platelets >= 100 x 10^9/L Platelets >=100,000/uL Platelets (PLT) >= 100 x 10^9/L without transfusions Platelets >=100x10^9/L Platelets >= 100,000/uL Platelets >= 100 x 10^9/L Platelets >= 100,000 x 10^9/L Platelets > 75 x 10^9/L Platelets >= 100,000/ul Platelets >= 100 x 10^9/L Platelets >= 100 x 10^9/L Platelets > 50,000/uL not supported by transfusions Platelets >= 100,000/ul Platelets >= 100,000/uL Platelets ? 100,000/µL Platelets >= 100,000/?L Platelets >= 100 x 10^9/L Platelets >= 100 x 10^9/L Platelets >= 100000/uL Platelets >= 100,000/mL Platelets >= 100,000/µL Platelets >= 100,000/ul Platelets > 100 K/uL Platelets > 100 K/uL Platelets > 125,000 cells/ul within 14 days prior to treatment initiation Platelets >100,000/µl Platelets (Plts) >= 50,000/uL Platelets >= 75,000/uL Platelets >= 50 x 10^3/uL Platelets >= 100 X 10^9/L Platelets < 25.000/µL. Platelets >= 50,000 Platelets >= 100 X 10^9/L Platelets >= 100,000/uL Platelets >= 100,000/uL Platelets >= 100,000/ul Hematology: ANC ? 1.5X109/L; Platelets >100x109/L. Platelets < 75,000/ microliter Platelets >= 100 x 10^9/L Platelets >= 100,000/mL Platelets < 125,000/µL Platelets >= 75,000/uL Platelets >= 100 x 10^3/uL Platelets >= 30,000/ul Platelets < 100 x 10^9/L Platelets (PLT) >= 75,000/uL Platelets > 100,000/ml Platelets > 100,000/ul Platelets >= 75 x 10^9/L Platelets > 100,000/uL Platelets (PLT) >= 90 x 10^9/L without transfusions Platelets >= 100 x 10^9/L Platelets >= 75 x 10^3/uL Platelets > 100,000/uL Platelets >= 75,000 Platelets >= 100 x 10^9/L Platelets (plts) > 90,000 Platelets > 100,000/uL Platelets >= 150,000/uL Platelets >= 100,000/microliter Platelets >= 100,000/uL Patients with platelets >= 100,000/uL (without platelets transfusion for at least one week prior to blood test date); the most recent platelets level taken within 60 days prior to study enrollment will be considered Within 30 days of surgery: Platelets >= 100,000/ml Platelets >= 100,000 cells/L Platelets less than 50,000 within 6 months prior to study enrollment or Platelets > 100,000 cells/ul Platelets >= 100,000 Platelets >= 100 x 10^3/uL, obtained within 14 days of the first dose of study drug Platelets >= 100 x 10^9/L Platelets >= 125 x 10^9/L (for Arm L pembrolizumab and Arm M nivolumab and expansion cohorts for all arms, platelets >= 100 x 10^9/L) Platelets >= 100,000/uL Platelets >= 100 x 10^9/L Platelets >= 20,000/ul without growth factor or transfusional support Platelets < 50 H K/UL in the past 30 days Platelets >= 100,000/ml Platelets >= 20,000/ul without growth factor or transfusional support Platelets >= 100,000/ml (within 30 days of surgery) Platelets > 50,000 Platelets < 50 H K/UL in the past 30 days Platelets >= 100,000/microliter Platelets >= 50 B/L (10^9/L) Platelets >= 100,000/microliter Platelets ? 75,000/?L Platelets >= 50,000/uL Platelets >= 100,000/microliter Platelets >= 100,000/microliter Platelets >= 50,000/microliter Platelets >= 100,000/microliter Platelets >= 100,000/microliter Platelets >= 150,000/microliter Platelets >= 100,000/uL Platelets >= 100,000/microliter Platelets >= 100,000/microliter Platelets >= 75,000 / uL Platelets >= 100,000/microliter Platelets >= 100,000/microliter Platelets >= 100,000/uL Platelets > 50,000/uL Platelets >= 100,000/microliter Platelets >= 100 B/L (10^9/L) Platelets >= 75 x 10^9/L Within 30 days of eligibility confirmation: Platelets >= 50,000/uL Platelets >= 100 x 10^9/L Platelets ? 75 x 10?/L Platelets ? 100 x 109/L Platelets (plt) ? 75,000/uL Platelets >= 100 x 10^9/L Platelets >= 75,000/uL Platelets >= 100 x 109/L Platelets >= 100 x 10^9/L Platelets >= 100,000 Platelets >= 75,000 cells/uL Platelets >= 75,000 cells/uL Platelets > 100,000 cells/uL Platelets > 50,000/uL Platelets > 100,000/uL Platelets >= 75,000 cells/uL Platelets >= 100 x 10^9/L Platelets < 100,000/?L Platelets >= 100,000/mL Platelets < 75,000/uL Platelets >= 100,000/uL Platelets >= 100 x 10^9/L Platelets > 50,000 Platelets > 100,000/ul Platelets >= 100 x 10^9/L Platelets ? 30,000/uL Platelets >= 75 X 10^9/L Thrombocytopenia (platelets < 100,000 cells/uL) Platelets ? 100 x 10E9/L Platelets <75 x 109/L Platelets > 100 x 109/L, Platelets ?100 x 109/L